Company Filing History:
Years Active: 2014
Title: Kevin Nell Dack: Innovator in ALK Inhibitors
Introduction
Kevin Nell Dack is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific proteins involved in cancer.
Latest Patents
Kevin Nell Dack holds a patent for "Alkoxy-substituted 2-aminopyridines as ALK inhibitors." This invention relates to compounds of Formula (1) and outlines processes for their preparation, intermediates used in the preparation, and the compositions containing these derivatives. The compounds are particularly useful in treating diseases where the ALK protein is involved, especially cancers mediated by a mutated EML4-ALK fusion protein. He has 1 patent to his name.
Career Highlights
Kevin is currently associated with Pfizer Corporation, a leading global biopharmaceutical company. His work focuses on innovative solutions for complex health challenges, particularly in oncology.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues, including Mark Edward Bunnage and Andrew Simon Cook. These partnerships have fostered advancements in drug development and therapeutic strategies.
Conclusion
Kevin Nell Dack's contributions to the field of ALK inhibitors highlight his commitment to advancing cancer treatment. His innovative work continues to impact the pharmaceutical industry positively.